data_1z3j_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1z3j _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 2.5 mmt . . . . . 0 N--CA 1.473 0.705 0 CA-C-O 119.0 -0.524 . . . . 0.0 111.685 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -173.7 -170.08 36.73 Favored Glycine 0 C--N 1.34 0.788 0 C-N-CA 130.069 3.699 . . . . 0.0 108.642 5.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -68.37 152.1 75.67 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 122.164 1.909 . . . . 0.0 108.265 170.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . 2.741 0.7 OUTLIER 136.21 36.67 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.392 1 N-CA-C 125.05 5.204 . . . . 0.0 125.05 -5.884 . . . . . . . . 4 3 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 15.0 m-90 -94.63 101.31 13.17 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-O 121.65 0.738 . . . . 0.0 110.6 171.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.424 ' H ' ' HD2' ' A' ' 110' ' ' ARG . 0.0 OUTLIER 11.27 -77.04 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 112.957 -1.929 . . . . 0.0 112.088 116.895 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 10.9 mptt -137.03 -69.91 0.46 Allowed 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.852 1.661 . . . . 0.0 109.628 -174.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 63.85 -66.54 0.11 Allowed 'General case' 0 C--N 1.344 0.329 0 C-N-CA 125.683 1.593 . . . . 0.0 109.193 -161.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -96.55 117.64 31.37 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 124.748 1.219 . . . . 0.0 109.998 -174.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . . . . . . . . . 4.6 mm -109.15 91.27 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 123.038 0.535 . . . . 0.0 109.735 175.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 9.0 p -81.99 129.35 34.76 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.223 -0.923 . . . . 0.0 108.515 172.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.415 ' CE1' ' CD2' ' A' ' 138' ' ' PHE . 41.2 p90 -130.62 160.41 34.3 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 123.181 0.592 . . . . 0.0 111.139 -177.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -148.39 141.81 25.29 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.839 0.856 . . . . 0.0 109.406 -172.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -97.09 146.88 6.86 Favored 'Isoleucine or valine' 0 C--O 1.231 0.112 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 169.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -96.4 -42.44 8.12 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 122.875 0.47 . . . . 0.0 110.118 -178.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -146.44 161.68 39.89 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.838 0.855 . . . . 0.0 109.292 175.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -113.48 124.83 53.32 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.938 1.295 . . . . 0.0 107.824 -172.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.1 t -62.97 134.46 95.76 Favored Pre-proline 0 CA--C 1.542 0.665 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -176.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -77.45 -18.34 13.93 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 123.487 2.791 . . . . 0.0 111.925 -177.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -49.7 -37.7 30.06 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.404 1.482 . . . . 0.0 111.668 -178.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 31.9 mtm -123.91 169.77 11.26 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.472 1.509 . . . . 0.0 108.3 177.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -75.91 145.34 40.53 Favored 'General case' 0 C--N 1.334 -0.086 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 174.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 27.6 ttt180 -47.45 -49.27 25.81 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -174.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -53.13 -46.42 68.78 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 118.182 0.446 . . . . 0.0 110.038 -176.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -56.02 -45.39 79.12 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 174.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 67.0 t -58.92 -57.71 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 C-N-CA 124.231 1.013 . . . . 0.0 109.436 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.23 -27.38 68.62 Favored 'General case' 0 C--O 1.218 -0.56 0 C-N-CA 117.8 -1.56 . . . . 0.0 109.476 177.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -65.01 -49.72 69.09 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 120.834 1.652 . . . . 0.0 110.61 -178.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.09 -50.9 63.46 Favored 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 123.342 0.657 . . . . 0.0 109.72 178.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -69.86 -39.71 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.409 -176.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 -56.16 -54.12 48.89 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -62.84 -48.93 76.93 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.345 0.658 . . . . 0.0 109.52 -178.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -46.28 -48.58 18.04 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.19 0.996 . . . . 0.0 111.729 173.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.415 ' CD2' ' CE1' ' A' ' 116' ' ' TYR . 4.8 m-85 -60.67 -51.7 68.26 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 122.247 1.022 . . . . 0.0 110.002 175.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -55.35 -37.36 67.37 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.179 0.991 . . . . 0.0 111.118 -173.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 94.5 t -46.26 -62.03 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 124.58 1.152 . . . . 0.0 109.357 175.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -68.9 -36.73 78.39 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 -173.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.1 t -59.77 -19.77 52.5 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.222 0.464 . . . . 0.0 111.804 -179.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -80.7 -46.12 16.05 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 118.31 0.504 . . . . 0.0 110.254 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -79.58 -46.17 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -177.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 75.8 p -86.16 152.77 56.23 Favored Pre-proline 0 N--CA 1.447 -0.616 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -74.14 -0.91 10.19 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.067 1.845 . . . . 0.0 112.562 174.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 9.2 mt -67.63 120.58 14.26 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 118.92 0.782 . . . . 0.0 109.818 -177.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 4.4 ttmt -99.41 93.86 6.12 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -170.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.41 ' CD2' ' CD2' ' A' ' 138' ' ' PHE . 70.2 m-85 -82.16 156.08 24.65 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -177.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 20.4 t -150.25 118.27 6.31 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.237 1.015 . . . . 0.0 110.475 174.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.97 130.35 34.98 Favored 'General case' 0 C--N 1.343 0.316 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 175.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 1.6 pp -125.13 118.44 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 172.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -78.81 -12.94 60.05 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.826 174.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -133.9 113.12 11.87 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.325 1.45 . . . . 0.0 109.207 -175.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 135.43 -145.68 17.72 Favored Glycine 0 C--N 1.337 0.617 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 170.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 57.0 mtt -111.9 136.06 51.71 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 126.053 1.741 . . . . 0.0 108.343 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -122.08 160.04 25.85 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 125.213 1.405 . . . . 0.0 109.634 177.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -76.24 -49.34 17.34 Favored 'General case' 0 C--O 1.231 0.109 0 C-N-CA 124.395 1.078 . . . . 0.0 108.232 177.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 23.3 pt -114.41 165.96 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.698 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.17 134.73 34.91 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.225 1.01 . . . . 0.0 109.988 -178.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 51.5 t -90.03 113.23 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 173.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 23.3 t -91.0 137.73 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 123.622 0.769 . . . . 0.0 109.311 176.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -127.77 108.88 11.11 Favored 'General case' 0 C--N 1.333 -0.13 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 170.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -123.3 -168.63 1.8 Allowed 'General case' 0 C--O 1.222 -0.361 0 C-N-CA 125.326 1.45 . . . . 0.0 108.241 177.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 20.9 ptt180 -155.7 130.09 8.94 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 175.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 61.83 -143.12 48.54 Favored Glycine 0 CA--C 1.534 1.224 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -173.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -75.51 117.27 17.11 Favored 'General case' 0 N--CA 1.455 -0.222 0 O-C-N 121.577 -0.955 . . . . 0.0 109.968 -169.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -120.02 9.47 11.21 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -176.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 95.49 44.32 3.22 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 -172.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -135.51 165.02 26.49 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 103.742 -2.688 . . . . 0.0 103.742 160.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -76.55 -56.68 4.4 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 45.6 m80 -69.56 -61.17 1.89 Allowed 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.643 -1.162 . . . . 0.0 108.908 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . 64.04 -67.0 0.11 Allowed 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 127.166 2.186 . . . . 0.0 113.933 178.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.523 ' CZ ' ' HA ' ' A' ' 198' ' ' ASP . 0.5 OUTLIER -166.93 171.78 10.9 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 124.001 0.92 . . . . 0.0 108.782 -152.285 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 8.4 p30 -174.64 20.97 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.238 0 O-C-N 123.76 0.663 . . . . 0.0 112.564 -169.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 54.55 -142.61 33.11 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 -172.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -70.75 106.26 3.5 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.102 0.561 . . . . 0.0 111.86 -168.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 110.94 -150.41 17.8 Favored Glycine 0 C--N 1.337 0.596 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 176.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 54.61 -118.06 9.0 Favored Glycine 0 C--N 1.338 0.656 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 -177.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 18.7 mm -76.97 127.1 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 172.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.566 ' HB2' ' H1 ' ' A' ' 269' ' ' NGH 0.43 6.9 mp -83.9 -39.22 20.1 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 124.293 1.037 . . . . 0.0 110.014 169.419 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.422 ' O ' ' N1 ' ' A' ' 269' ' ' NGH . . . -177.3 161.13 1.77 Allowed 'General case' 0 C--O 1.242 0.674 0 CA-C-N 119.181 0.901 . . . . 0.0 112.771 172.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 32.1 p-80 -140.03 121.84 15.45 Favored 'General case' 0 C--O 1.225 -0.187 0 C-N-CA 124.226 1.01 . . . . 0.0 112.175 -170.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -151.38 159.34 44.31 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 126.329 1.851 . . . . 0.0 106.593 -172.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -149.94 155.82 40.64 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 178.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -103.69 -85.4 1.86 Allowed Glycine 0 CA--C 1.53 1.011 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 173.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.23 84.53 0.73 Allowed 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 124.063 3.175 . . . . 0.0 111.007 -174.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -160.46 167.04 35.56 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 108.627 -1.789 . . . . 0.0 108.627 170.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 5.7 m -78.03 166.55 22.68 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 122.817 0.447 . . . . 0.0 110.228 179.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 53.01 -100.25 0.06 OUTLIER Glycine 0 C--N 1.338 0.672 0 C-N-CA 124.185 0.898 . . . . 0.0 112.672 170.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 7.1 tp -59.49 -40.43 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 CA-C-O 118.275 -0.869 . . . . 0.0 109.426 -178.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -38.49 134.63 1.3 Allowed Glycine 0 CA--C 1.534 1.264 0 C-N-CA 124.026 0.822 . . . . 0.0 112.783 176.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 99.21 -43.86 1.77 Allowed Glycine 0 CA--C 1.533 1.209 0 C-N-CA 125.524 1.535 . . . . 0.0 111.142 -163.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -85.61 152.82 22.83 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 117.989 0.894 . . . . 0.0 109.546 -160.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -128.91 121.29 27.81 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 123.002 0.521 . . . . 0.0 111.873 -171.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 2.1 m170 -109.2 112.8 25.17 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 118.16 -0.924 . . . . 0.0 110.175 -167.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -97.97 151.37 20.37 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 118.897 0.771 . . . . 0.0 112.317 -177.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.523 ' HA ' ' CZ ' ' A' ' 174' ' ' PHE . 3.0 t70 -75.22 66.49 1.72 Allowed 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.332 -176.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -46.81 -41.35 15.35 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 120.183 -1.573 . . . . 0.0 110.996 178.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -49.67 -31.28 10.68 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 118.573 0.624 . . . . 0.0 112.623 177.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -71.8 165.46 24.04 Favored 'General case' 0 C--O 1.243 0.736 0 CA-C-O 123.411 1.577 . . . . 0.0 112.269 172.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -107.23 90.1 3.2 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.073 -1.421 . . . . 0.0 107.422 177.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -77.15 152.33 34.93 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.058 -0.974 . . . . 0.0 108.57 -178.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 61.5 p -132.39 152.49 51.43 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 121.419 0.628 . . . . 0.0 110.302 178.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.88 -50.56 16.51 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 170.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -69.51 171.22 9.16 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 173.075 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -49.28 -53.93 19.42 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 125.834 1.654 . . . . 0.0 110.326 -174.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 39.38 -106.89 0.06 OUTLIER Glycine 0 CA--C 1.528 0.864 0 C-N-CA 125.893 1.711 . . . . 0.0 114.273 170.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -107.6 -81.38 1.36 Allowed Glycine 0 CA--C 1.524 0.623 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -177.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 4.4 m -119.36 137.44 53.72 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 170.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -86.2 124.73 32.92 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.177 176.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.61 -57.26 11.41 Favored 'General case' 0 C--N 1.341 0.209 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -49.26 -46.15 45.78 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.681 0.793 . . . . 0.0 110.405 -178.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 6.0 tt -63.08 -59.07 5.29 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.387 0.675 . . . . 0.0 110.037 -171.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.278 5.0 m -57.27 -42.2 81.19 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 120.4 -0.52 . . . . 0.0 109.992 176.364 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -51.59 -53.09 41.98 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 117.4 -1.286 . . . . 0.0 110.935 178.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 79.1 t -47.04 -53.51 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 120.896 1.68 . . . . 0.0 111.176 177.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . 0.774 ' HD1' ' H4 ' ' A' ' 269' ' ' NGH . 3.2 t-160 -52.13 -60.09 3.61 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.674 1.59 . . . . 0.0 110.986 175.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -61.71 -37.33 83.77 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 120.624 -1.297 . . . . 0.0 112.767 -177.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 1.3 mp -71.27 -36.35 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 O-C-N 120.952 -1.093 . . . . 0.0 108.335 -177.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -54.51 -47.55 69.21 Favored Glycine 0 CA--C 1.537 1.441 0 O-C-N 121.426 -0.796 . . . . 0.0 111.722 165.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 7.5 m-70 -53.15 -47.77 68.47 Favored 'General case' 0 C--N 1.345 0.379 0 CA-C-N 118.421 1.111 . . . . 0.0 109.83 173.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 32.9 t -52.95 -45.65 67.8 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 123.952 0.783 . . . . 0.0 111.136 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 22.0 mt -55.64 -53.64 54.04 Favored 'General case' 0 C--N 1.341 0.199 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 174.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 143.81 52.86 0.03 OUTLIER Glycine 0 C--N 1.334 0.469 0 O-C-N 123.633 0.583 . . . . 0.0 112.665 169.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 6.5 mt -106.55 117.83 35.08 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -169.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -73.9 95.64 0.83 Allowed Glycine 0 CA--C 1.528 0.873 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 167.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 51.5 m80 7.84 113.75 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 128.47 2.708 . . . . 0.0 116.824 163.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 15.4 m -75.46 179.54 5.19 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.252 0.548 . . . . 0.0 110.592 175.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 10.5 m -136.49 30.2 2.92 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.815 1.246 . . . . 0.0 110.342 -170.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -129.77 139.81 36.76 Favored Pre-proline 0 N--CA 1.45 -0.442 0 C-N-CA 125.55 1.54 . . . . 0.0 107.255 -175.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -84.09 -16.54 6.15 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.336 2.024 . . . . 0.0 114.416 -173.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 14.8 mtmt -82.02 -33.65 29.93 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.657 0.783 . . . . 0.0 108.914 173.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -60.04 146.99 40.8 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.325 0.583 . . . . 0.0 109.814 171.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 90.9 t -95.06 -23.76 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.431 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 1.4 mmm -63.83 -16.22 60.77 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 -179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.598 ' O ' ' CE1' ' A' ' 218' ' ' HIS . 0.1 OUTLIER -53.32 160.8 1.61 Allowed Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -176.897 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.408 ' O ' ' H5 ' ' A' ' 269' ' ' NGH . 74.2 Cg_endo -72.58 -19.08 25.03 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 121.157 1.238 . . . . 0.0 111.152 175.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.272 0.0 OUTLIER -76.81 -178.23 4.74 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.12 1.768 . . . . 0.0 110.448 -176.086 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -131.4 144.03 50.91 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 172.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -152.29 129.99 11.58 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 174.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -60.87 122.65 15.38 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 4.0 m -119.92 143.08 32.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 C-N-CA 123.896 0.879 . . . . 0.0 110.345 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -73.09 113.56 10.27 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.716 0.807 . . . . 0.0 110.747 177.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -65.91 -8.88 7.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.912 168.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -68.43 -65.93 0.64 Allowed 'General case' 0 C--N 1.34 0.154 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 167.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 22.4 m -58.89 -43.86 91.04 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.57 1.148 . . . . 0.0 111.264 -176.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 7.4 t80 40.64 85.02 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.042 1.337 . . . . 0.0 114.35 165.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 1.5 ppt_? -160.27 176.53 11.61 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 167.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -102.96 159.95 15.05 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.335 1.054 . . . . 0.0 109.227 178.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 20.9 m -80.03 153.58 28.72 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.733 -0.212 . . . . 0.0 111.184 178.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -53.85 -46.98 71.41 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 122.887 0.475 . . . . 0.0 110.37 174.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -49.21 -56.62 8.71 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 122.079 0.942 . . . . 0.0 109.999 173.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -57.9 -46.11 85.42 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 114.308 -1.314 . . . . 0.0 109.981 -174.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 58.8 mt -51.99 -36.66 20.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 125.836 1.654 . . . . 0.0 112.103 175.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -66.71 -50.15 63.74 Favored 'General case' 0 C--O 1.231 0.13 0 O-C-N 120.465 -1.397 . . . . 0.0 110.158 174.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -47.12 -56.64 7.66 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 176.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 2.1 pp -64.23 -41.27 91.87 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.128 0 O-C-N 122.404 -0.468 . . . . 0.0 111.111 -175.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -60.63 -28.59 68.66 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 120.773 -1.204 . . . . 0.0 111.58 174.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.15 -6.48 1.44 Allowed 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 169.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 33.9 mt -62.4 -2.97 1.18 Allowed 'General case' 0 CA--C 1.545 0.784 0 O-C-N 118.247 -2.783 . . . . 0.0 115.615 175.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . 0.417 ' CD2' ' HA3' ' A' ' 263' ' ' GLY 0.3 0.9 OUTLIER -72.93 -54.07 9.64 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 121.805 2.093 . . . . 0.0 111.259 -179.684 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . 0.417 ' HA3' ' CD2' ' A' ' 262' ' ' TYR . . . . . . . . 0 C--O 1.252 1.255 0 C-N-CA 130.218 3.77 . . . . 0.0 117.618 -38.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' NGH . . . . . 0.774 ' H4 ' ' HD1' ' A' ' 218' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 2.5 mmt . . . . . 0 N--CA 1.473 0.705 0 CA-C-O 119.0 -0.524 . . . . 0.0 111.685 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -173.7 -170.08 36.73 Favored Glycine 0 C--N 1.34 0.788 0 C-N-CA 130.069 3.699 . . . . 0.0 108.642 5.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.439 ' HA ' ' HA ' ' A' ' 108' ' ' VAL . 83.7 Cg_endo -68.37 152.1 75.67 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 122.164 1.909 . . . . 0.0 108.265 170.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.439 ' HA ' ' HA ' ' A' ' 107' ' ' PRO 2.741 0.7 OUTLIER 136.21 36.67 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.392 1 N-CA-C 125.05 5.204 . . . . 0.0 125.05 -5.884 . . . . . . . . 5 4 . 1 . 001 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 15.0 m-90 -94.63 101.31 13.17 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-O 121.65 0.738 . . . . 0.0 110.6 171.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 11.27 -77.04 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 112.957 -1.929 . . . . 0.0 112.088 116.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.411 ' HG2' ' CD1' ' A' ' 114' ' ' ILE . 10.9 mptt -137.03 -69.91 0.46 Allowed 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.852 1.661 . . . . 0.0 109.628 -174.408 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 63.85 -66.54 0.11 Allowed 'General case' 0 C--N 1.344 0.329 0 C-N-CA 125.683 1.593 . . . . 0.0 109.193 -161.065 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -96.55 117.64 31.37 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 124.748 1.219 . . . . 0.0 109.998 -174.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.411 ' CD1' ' HG2' ' A' ' 111' ' ' LYS . 4.6 mm -109.15 91.27 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 123.038 0.535 . . . . 0.0 109.735 175.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 9.0 p -81.99 129.35 34.76 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.223 -0.923 . . . . 0.0 108.515 172.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.415 ' CE1' ' CD2' ' A' ' 138' ' ' PHE . 41.2 p90 -130.62 160.41 34.3 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 123.181 0.592 . . . . 0.0 111.139 -177.243 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -148.39 141.81 25.29 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.839 0.856 . . . . 0.0 109.406 -172.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -97.09 146.88 6.86 Favored 'Isoleucine or valine' 0 C--O 1.231 0.112 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 169.307 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASN . . . . . 0.414 HD21 ' H ' ' A' ' 163' ' ' PHE . 1.9 p30 -96.4 -42.44 8.12 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 122.875 0.47 . . . . 0.0 110.118 -178.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -146.44 161.68 39.89 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.838 0.855 . . . . 0.0 109.292 175.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -113.48 124.83 53.32 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.938 1.295 . . . . 0.0 107.824 -172.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.1 t -62.97 134.46 95.76 Favored Pre-proline 0 CA--C 1.542 0.665 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -176.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -77.45 -18.34 13.93 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 123.487 2.791 . . . . 0.0 111.925 -177.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -49.7 -37.7 30.06 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.404 1.482 . . . . 0.0 111.668 -178.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 31.9 mtm -123.91 169.77 11.26 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.472 1.509 . . . . 0.0 108.3 177.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -75.91 145.34 40.53 Favored 'General case' 0 C--N 1.334 -0.086 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 174.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 27.6 ttt180 -47.45 -49.27 25.81 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -174.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -53.13 -46.42 68.78 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 118.182 0.446 . . . . 0.0 110.038 -176.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -56.02 -45.39 79.12 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 174.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 67.0 t -58.92 -57.71 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 C-N-CA 124.231 1.013 . . . . 0.0 109.436 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.23 -27.38 68.62 Favored 'General case' 0 C--O 1.218 -0.56 0 C-N-CA 117.8 -1.56 . . . . 0.0 109.476 177.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -65.01 -49.72 69.09 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 120.834 1.652 . . . . 0.0 110.61 -178.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.09 -50.9 63.46 Favored 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 123.342 0.657 . . . . 0.0 109.72 178.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -69.86 -39.71 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.409 -176.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 -56.16 -54.12 48.89 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.561 ' O ' HG23 ' A' ' 140' ' ' VAL . 11.5 mmmm -62.84 -48.93 76.93 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.345 0.658 . . . . 0.0 109.52 -178.395 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -46.28 -48.58 18.04 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.19 0.996 . . . . 0.0 111.729 173.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.415 ' CD2' ' CE1' ' A' ' 116' ' ' TYR . 4.8 m-85 -60.67 -51.7 68.26 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 122.247 1.022 . . . . 0.0 110.002 175.306 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -55.35 -37.36 67.37 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.179 0.991 . . . . 0.0 111.118 -173.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.736 HG22 ' CE1' ' A' ' 248' ' ' PHE . 94.5 t -46.26 -62.03 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 124.58 1.152 . . . . 0.0 109.357 175.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.88 ' CZ3' HG21 ' A' ' 258' ' ' ILE . 84.9 m95 -68.9 -36.73 78.39 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 -173.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.1 t -59.77 -19.77 52.5 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.222 0.464 . . . . 0.0 111.804 -179.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -80.7 -46.12 16.05 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 118.31 0.504 . . . . 0.0 110.254 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -79.58 -46.17 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -177.318 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 75.8 p -86.16 152.77 56.23 Favored Pre-proline 0 N--CA 1.447 -0.616 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -74.14 -0.91 10.19 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.067 1.845 . . . . 0.0 112.562 174.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 9.2 mt -67.63 120.58 14.26 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 118.92 0.782 . . . . 0.0 109.818 -177.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 4.4 ttmt -99.41 93.86 6.12 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -170.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.496 ' CZ ' HD21 ' A' ' 224' ' ' LEU . 70.2 m-85 -82.16 156.08 24.65 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -177.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 20.4 t -150.25 118.27 6.31 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.237 1.015 . . . . 0.0 110.475 174.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.97 130.35 34.98 Favored 'General case' 0 C--N 1.343 0.316 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 175.201 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 1.6 pp -125.13 118.44 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 172.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -78.81 -12.94 60.05 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.826 174.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -133.9 113.12 11.87 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.325 1.45 . . . . 0.0 109.207 -175.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 135.43 -145.68 17.72 Favored Glycine 0 C--N 1.337 0.617 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 170.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 57.0 mtt -111.9 136.06 51.71 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 126.053 1.741 . . . . 0.0 108.343 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -122.08 160.04 25.85 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 125.213 1.405 . . . . 0.0 109.634 177.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -76.24 -49.34 17.34 Favored 'General case' 0 C--O 1.231 0.109 0 C-N-CA 124.395 1.078 . . . . 0.0 108.232 177.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 23.3 pt -114.41 165.96 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.698 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.17 134.73 34.91 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.225 1.01 . . . . 0.0 109.988 -178.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 51.5 t -90.03 113.23 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 173.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 23.3 t -91.0 137.73 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 123.622 0.769 . . . . 0.0 109.311 176.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.414 ' H ' HD21 ' A' ' 119' ' ' ASN . 14.3 m-85 -127.77 108.88 11.11 Favored 'General case' 0 C--N 1.333 -0.13 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 170.001 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -123.3 -168.63 1.8 Allowed 'General case' 0 C--O 1.222 -0.361 0 C-N-CA 125.326 1.45 . . . . 0.0 108.241 177.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 20.9 ptt180 -155.7 130.09 8.94 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 175.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 61.83 -143.12 48.54 Favored Glycine 0 CA--C 1.534 1.224 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -173.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -75.51 117.27 17.11 Favored 'General case' 0 N--CA 1.455 -0.222 0 O-C-N 121.577 -0.955 . . . . 0.0 109.968 -169.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -120.02 9.47 11.21 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -176.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 95.49 44.32 3.22 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 -172.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -135.51 165.02 26.49 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 103.742 -2.688 . . . . 0.0 103.742 160.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -76.55 -56.68 4.4 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 45.6 m80 -69.56 -61.17 1.89 Allowed 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.643 -1.162 . . . . 0.0 108.908 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . 64.04 -67.0 0.11 Allowed 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 127.166 2.186 . . . . 0.0 113.933 178.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.597 ' CZ ' ' HA ' ' A' ' 198' ' ' ASP . 0.5 OUTLIER -166.93 171.78 10.9 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 124.001 0.92 . . . . 0.0 108.782 -152.285 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 8.4 p30 -174.64 20.97 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.238 0 O-C-N 123.76 0.663 . . . . 0.0 112.564 -169.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 54.55 -142.61 33.11 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 -172.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -70.75 106.26 3.5 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.102 0.561 . . . . 0.0 111.86 -168.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 110.94 -150.41 17.8 Favored Glycine 0 C--N 1.337 0.596 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 176.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 54.61 -118.06 9.0 Favored Glycine 0 C--N 1.338 0.656 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 -177.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 18.7 mm -76.97 127.1 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 172.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.737 ' HB2' ' H1 ' ' A' ' 269' ' ' NGH 0.43 6.9 mp -83.9 -39.22 20.1 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 124.293 1.037 . . . . 0.0 110.014 169.419 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.411 ' O ' ' N1 ' ' A' ' 269' ' ' NGH . . . -177.3 161.13 1.77 Allowed 'General case' 0 C--O 1.242 0.674 0 CA-C-N 119.181 0.901 . . . . 0.0 112.771 172.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 32.1 p-80 -140.03 121.84 15.45 Favored 'General case' 0 C--O 1.225 -0.187 0 C-N-CA 124.226 1.01 . . . . 0.0 112.175 -170.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -151.38 159.34 44.31 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 126.329 1.851 . . . . 0.0 106.593 -172.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -149.94 155.82 40.64 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 178.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -103.69 -85.4 1.86 Allowed Glycine 0 CA--C 1.53 1.011 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 173.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.23 84.53 0.73 Allowed 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 124.063 3.175 . . . . 0.0 111.007 -174.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -160.46 167.04 35.56 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 108.627 -1.789 . . . . 0.0 108.627 170.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 5.7 m -78.03 166.55 22.68 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 122.817 0.447 . . . . 0.0 110.228 179.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 53.01 -100.25 0.06 OUTLIER Glycine 0 C--N 1.338 0.672 0 C-N-CA 124.185 0.898 . . . . 0.0 112.672 170.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 7.1 tp -59.49 -40.43 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 CA-C-O 118.275 -0.869 . . . . 0.0 109.426 -178.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -38.49 134.63 1.3 Allowed Glycine 0 CA--C 1.534 1.264 0 C-N-CA 124.026 0.822 . . . . 0.0 112.783 176.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 99.21 -43.86 1.77 Allowed Glycine 0 CA--C 1.533 1.209 0 C-N-CA 125.524 1.535 . . . . 0.0 111.142 -163.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -85.61 152.82 22.83 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 117.989 0.894 . . . . 0.0 109.546 -160.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -128.91 121.29 27.81 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 123.002 0.521 . . . . 0.0 111.873 -171.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 2.1 m170 -109.2 112.8 25.17 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 118.16 -0.924 . . . . 0.0 110.175 -167.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -97.97 151.37 20.37 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 118.897 0.771 . . . . 0.0 112.317 -177.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.597 ' HA ' ' CZ ' ' A' ' 174' ' ' PHE . 3.0 t70 -75.22 66.49 1.72 Allowed 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.332 -176.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -46.81 -41.35 15.35 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 120.183 -1.573 . . . . 0.0 110.996 178.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -49.67 -31.28 10.68 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 118.573 0.624 . . . . 0.0 112.623 177.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -71.8 165.46 24.04 Favored 'General case' 0 C--O 1.243 0.736 0 CA-C-O 123.411 1.577 . . . . 0.0 112.269 172.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -107.23 90.1 3.2 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.073 -1.421 . . . . 0.0 107.422 177.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -77.15 152.33 34.93 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.058 -0.974 . . . . 0.0 108.57 -178.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 61.5 p -132.39 152.49 51.43 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 121.419 0.628 . . . . 0.0 110.302 178.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.88 -50.56 16.51 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 170.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -69.51 171.22 9.16 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 173.075 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -49.28 -53.93 19.42 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 125.834 1.654 . . . . 0.0 110.326 -174.288 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 39.38 -106.89 0.06 OUTLIER Glycine 0 CA--C 1.528 0.864 0 C-N-CA 125.893 1.711 . . . . 0.0 114.273 170.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -107.6 -81.38 1.36 Allowed Glycine 0 CA--C 1.524 0.623 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -177.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 4.4 m -119.36 137.44 53.72 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 170.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -86.2 124.73 32.92 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.177 176.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.61 -57.26 11.41 Favored 'General case' 0 C--N 1.341 0.209 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.243 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -49.26 -46.15 45.78 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.681 0.793 . . . . 0.0 110.405 -178.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 6.0 tt -63.08 -59.07 5.29 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.387 0.675 . . . . 0.0 110.037 -171.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.278 5.0 m -57.27 -42.2 81.19 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 120.4 -0.52 . . . . 0.0 109.992 176.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -51.59 -53.09 41.98 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 117.4 -1.286 . . . . 0.0 110.935 178.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 79.1 t -47.04 -53.51 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 120.896 1.68 . . . . 0.0 111.176 177.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.694 ' ND1' ' H4 ' ' A' ' 269' ' ' NGH . 3.2 t-160 -52.13 -60.09 3.61 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.674 1.59 . . . . 0.0 110.986 175.055 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -61.71 -37.33 83.77 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 120.624 -1.297 . . . . 0.0 112.767 -177.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 1.3 mp -71.27 -36.35 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 O-C-N 120.952 -1.093 . . . . 0.0 108.335 -177.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' GLY . . . . . 0.411 ' HA3' ' SD ' ' A' ' 236' ' ' MET . . . -54.51 -47.55 69.21 Favored Glycine 0 CA--C 1.537 1.441 0 O-C-N 121.426 -0.796 . . . . 0.0 111.722 165.204 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 7.5 m-70 -53.15 -47.77 68.47 Favored 'General case' 0 C--N 1.345 0.379 0 CA-C-N 118.421 1.111 . . . . 0.0 109.83 173.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 32.9 t -52.95 -45.65 67.8 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 123.952 0.783 . . . . 0.0 111.136 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.496 HD21 ' CZ ' ' A' ' 149' ' ' PHE . 22.0 mt -55.64 -53.64 54.04 Favored 'General case' 0 C--N 1.341 0.199 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 174.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 143.81 52.86 0.03 OUTLIER Glycine 0 C--N 1.334 0.469 0 O-C-N 123.633 0.583 . . . . 0.0 112.665 169.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.716 HD11 HG22 ' A' ' 258' ' ' ILE . 6.5 mt -106.55 117.83 35.08 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -169.318 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -73.9 95.64 0.83 Allowed Glycine 0 CA--C 1.528 0.873 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 167.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 51.5 m80 7.84 113.75 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 128.47 2.708 . . . . 0.0 116.824 163.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 15.4 m -75.46 179.54 5.19 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.252 0.548 . . . . 0.0 110.592 175.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 10.5 m -136.49 30.2 2.92 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.815 1.246 . . . . 0.0 110.342 -170.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -129.77 139.81 36.76 Favored Pre-proline 0 N--CA 1.45 -0.442 0 C-N-CA 125.55 1.54 . . . . 0.0 107.255 -175.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -84.09 -16.54 6.15 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.336 2.024 . . . . 0.0 114.416 -173.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 14.8 mtmt -82.02 -33.65 29.93 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.657 0.783 . . . . 0.0 108.914 173.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -60.04 146.99 40.8 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.325 0.583 . . . . 0.0 109.814 171.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 90.9 t -95.06 -23.76 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.431 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' MET . . . . . 0.411 ' SD ' ' HA3' ' A' ' 221' ' ' GLY . 1.4 mmm -63.83 -16.22 60.77 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.598 ' O ' ' CE1' ' A' ' 218' ' ' HIS . 0.1 OUTLIER -53.32 160.8 1.61 Allowed Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -176.897 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.403 ' O ' ' H5 ' ' A' ' 269' ' ' NGH . 74.2 Cg_endo -72.58 -19.08 25.03 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 121.157 1.238 . . . . 0.0 111.152 175.011 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.272 0.0 OUTLIER -76.81 -178.23 4.74 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.12 1.768 . . . . 0.0 110.448 -176.086 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -131.4 144.03 50.91 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 172.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -152.29 129.99 11.58 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 174.59 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -60.87 122.65 15.38 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 4.0 m -119.92 143.08 32.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 C-N-CA 123.896 0.879 . . . . 0.0 110.345 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -73.09 113.56 10.27 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.716 0.807 . . . . 0.0 110.747 177.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -65.91 -8.88 7.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.912 168.278 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -68.43 -65.93 0.64 Allowed 'General case' 0 C--N 1.34 0.154 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 167.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 22.4 m -58.89 -43.86 91.04 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.57 1.148 . . . . 0.0 111.264 -176.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.736 ' CE1' HG22 ' A' ' 140' ' ' VAL . 7.4 t80 40.64 85.02 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.042 1.337 . . . . 0.0 114.35 165.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 1.5 ppt_? -160.27 176.53 11.61 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 167.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.474 HD22 ' N ' ' A' ' 250' ' ' LEU . 1.5 mm? -102.96 159.95 15.05 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.335 1.054 . . . . 0.0 109.227 178.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 20.9 m -80.03 153.58 28.72 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.733 -0.212 . . . . 0.0 111.184 178.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -53.85 -46.98 71.41 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 122.887 0.475 . . . . 0.0 110.37 174.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -49.21 -56.62 8.71 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 122.079 0.942 . . . . 0.0 109.999 173.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -57.9 -46.11 85.42 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 114.308 -1.314 . . . . 0.0 109.981 -174.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 58.8 mt -51.99 -36.66 20.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 125.836 1.654 . . . . 0.0 112.103 175.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -66.71 -50.15 63.74 Favored 'General case' 0 C--O 1.231 0.13 0 O-C-N 120.465 -1.397 . . . . 0.0 110.158 174.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -47.12 -56.64 7.66 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 176.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.88 HG21 ' CZ3' ' A' ' 141' ' ' TRP . 2.1 pp -64.23 -41.27 91.87 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.128 0 O-C-N 122.404 -0.468 . . . . 0.0 111.111 -175.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -60.63 -28.59 68.66 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 120.773 -1.204 . . . . 0.0 111.58 174.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.15 -6.48 1.44 Allowed 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 169.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 33.9 mt -62.4 -2.97 1.18 Allowed 'General case' 0 CA--C 1.545 0.784 0 O-C-N 118.247 -2.783 . . . . 0.0 115.615 175.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 262' ' ' TYR . . . . . 0.435 ' CD2' ' HA3' ' A' ' 263' ' ' GLY 0.3 0.9 OUTLIER -72.93 -54.07 9.64 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 121.805 2.093 . . . . 0.0 111.259 -179.684 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 263' ' ' GLY . . . . . 0.435 ' HA3' ' CD2' ' A' ' 262' ' ' TYR . . . . . . . . 0 C--O 1.252 1.255 0 C-N-CA 130.218 3.77 . . . . 0.0 117.618 -38.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 269' ' ' NGH . . . . . 0.737 ' H1 ' ' HB2' ' A' ' 181' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 2.5 mmt . . . . . 0 N--CA 1.473 0.705 0 CA-C-O 119.0 -0.524 . . . . 0.0 111.685 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -173.7 -170.08 36.73 Favored Glycine 0 C--N 1.34 0.788 0 C-N-CA 130.069 3.699 . . . . 0.0 108.642 5.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.439 ' HA ' ' HA ' ' A' ' 108' ' ' VAL . 83.7 Cg_endo -68.37 152.1 75.67 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 122.164 1.909 . . . . 0.0 108.265 170.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.439 ' HA ' ' HA ' ' A' ' 107' ' ' PRO 2.741 0.7 OUTLIER 136.21 36.67 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.392 1 N-CA-C 125.05 5.204 . . . . 0.0 125.05 -5.884 . . . . . . . . 5 4 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 15.0 m-90 -94.63 101.31 13.17 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-O 121.65 0.738 . . . . 0.0 110.6 171.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 11.27 -77.04 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 112.957 -1.929 . . . . 0.0 112.088 116.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.411 ' HG2' ' CD1' ' A' ' 114' ' ' ILE . 10.9 mptt -137.03 -69.91 0.46 Allowed 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.852 1.661 . . . . 0.0 109.628 -174.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 63.85 -66.54 0.11 Allowed 'General case' 0 C--N 1.344 0.329 0 C-N-CA 125.683 1.593 . . . . 0.0 109.193 -161.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 81.8 m-85 -96.55 117.64 31.37 Favored 'General case' 0 N--CA 1.44 -0.939 0 C-N-CA 124.748 1.219 . . . . 0.0 109.998 -174.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.411 ' CD1' ' HG2' ' A' ' 111' ' ' LYS . 4.6 mm -109.15 91.27 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 123.038 0.535 . . . . 0.0 109.735 175.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 9.0 p -81.99 129.35 34.76 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.223 -0.923 . . . . 0.0 108.515 172.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.415 ' CE1' ' CD2' ' A' ' 138' ' ' PHE . 41.2 p90 -130.62 160.41 34.3 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 123.181 0.592 . . . . 0.0 111.139 -177.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -148.39 141.81 25.29 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 123.839 0.856 . . . . 0.0 109.406 -172.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -97.09 146.88 6.86 Favored 'Isoleucine or valine' 0 C--O 1.231 0.112 0 N-CA-C 107.938 -1.134 . . . . 0.0 107.938 169.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . 0.414 HD21 ' H ' ' A' ' 163' ' ' PHE . 1.9 p30 -96.4 -42.44 8.12 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 122.875 0.47 . . . . 0.0 110.118 -178.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -146.44 161.68 39.89 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 123.838 0.855 . . . . 0.0 109.292 175.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -113.48 124.83 53.32 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.938 1.295 . . . . 0.0 107.824 -172.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 1.1 t -62.97 134.46 95.76 Favored Pre-proline 0 CA--C 1.542 0.665 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -176.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -77.45 -18.34 13.93 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 123.487 2.791 . . . . 0.0 111.925 -177.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -49.7 -37.7 30.06 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.404 1.482 . . . . 0.0 111.668 -178.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 31.9 mtm -123.91 169.77 11.26 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.472 1.509 . . . . 0.0 108.3 177.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -75.91 145.34 40.53 Favored 'General case' 0 C--N 1.334 -0.086 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 174.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 27.6 ttt180 -47.45 -49.27 25.81 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -174.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -53.13 -46.42 68.78 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 118.182 0.446 . . . . 0.0 110.038 -176.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -56.02 -45.39 79.12 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 174.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 67.0 t -58.92 -57.71 10.06 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.817 0 C-N-CA 124.231 1.013 . . . . 0.0 109.436 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -65.23 -27.38 68.62 Favored 'General case' 0 C--O 1.218 -0.56 0 C-N-CA 117.8 -1.56 . . . . 0.0 109.476 177.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 53.0 t80 -65.01 -49.72 69.09 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 120.834 1.652 . . . . 0.0 110.61 -178.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -53.09 -50.9 63.46 Favored 'General case' 0 N--CA 1.441 -0.887 0 C-N-CA 123.342 0.657 . . . . 0.0 109.72 178.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -69.86 -39.71 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.409 -176.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 58.2 ttt180 -56.16 -54.12 48.89 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.561 ' O ' HG23 ' A' ' 140' ' ' VAL . 11.5 mmmm -62.84 -48.93 76.93 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.345 0.658 . . . . 0.0 109.52 -178.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . . . . . . . . . . . -46.28 -48.58 18.04 Favored 'General case' 0 N--CA 1.465 0.32 0 C-N-CA 124.19 0.996 . . . . 0.0 111.729 173.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.415 ' CD2' ' CE1' ' A' ' 116' ' ' TYR . 4.8 m-85 -60.67 -51.7 68.26 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 122.247 1.022 . . . . 0.0 110.002 175.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -55.35 -37.36 67.37 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.179 0.991 . . . . 0.0 111.118 -173.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.736 HG22 ' CE1' ' A' ' 248' ' ' PHE . 94.5 t -46.26 -62.03 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 124.58 1.152 . . . . 0.0 109.357 175.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.88 ' CZ3' HG21 ' A' ' 258' ' ' ILE . 84.9 m95 -68.9 -36.73 78.39 Favored 'General case' 0 N--CA 1.434 -1.232 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 -173.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.1 t -59.77 -19.77 52.5 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.222 0.464 . . . . 0.0 111.804 -179.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -80.7 -46.12 16.05 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 118.31 0.504 . . . . 0.0 110.254 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -79.58 -46.17 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.176 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -177.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . . . . . . . . . 75.8 p -86.16 152.77 56.23 Favored Pre-proline 0 N--CA 1.447 -0.616 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -74.14 -0.91 10.19 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.067 1.845 . . . . 0.0 112.562 174.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 9.2 mt -67.63 120.58 14.26 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 118.92 0.782 . . . . 0.0 109.818 -177.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 4.4 ttmt -99.41 93.86 6.12 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 -170.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.496 ' CZ ' HD21 ' A' ' 224' ' ' LEU . 70.2 m-85 -82.16 156.08 24.65 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 -177.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 20.4 t -150.25 118.27 6.31 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.237 1.015 . . . . 0.0 110.475 174.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.97 130.35 34.98 Favored 'General case' 0 C--N 1.343 0.316 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 175.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 1.6 pp -125.13 118.44 52.9 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 172.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 10.8 m120 -78.81 -12.94 60.05 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 115.817 -0.628 . . . . 0.0 109.826 174.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -133.9 113.12 11.87 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.325 1.45 . . . . 0.0 109.207 -175.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 135.43 -145.68 17.72 Favored Glycine 0 C--N 1.337 0.617 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 170.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 57.0 mtt -111.9 136.06 51.71 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 126.053 1.741 . . . . 0.0 108.343 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -122.08 160.04 25.85 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 125.213 1.405 . . . . 0.0 109.634 177.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 15.0 t0 -76.24 -49.34 17.34 Favored 'General case' 0 C--O 1.231 0.109 0 C-N-CA 124.395 1.078 . . . . 0.0 108.232 177.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . . . . . . . . . 23.3 pt -114.41 165.96 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.698 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -138.17 134.73 34.91 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.225 1.01 . . . . 0.0 109.988 -178.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 51.5 t -90.03 113.23 25.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 173.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 23.3 t -91.0 137.73 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 C-N-CA 123.622 0.769 . . . . 0.0 109.311 176.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.414 ' H ' HD21 ' A' ' 119' ' ' ASN . 14.3 m-85 -127.77 108.88 11.11 Favored 'General case' 0 C--N 1.333 -0.13 0 N-CA-C 105.446 -2.057 . . . . 0.0 105.446 170.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -123.3 -168.63 1.8 Allowed 'General case' 0 C--O 1.222 -0.361 0 C-N-CA 125.326 1.45 . . . . 0.0 108.241 177.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 20.9 ptt180 -155.7 130.09 8.94 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 107.057 -1.46 . . . . 0.0 107.057 175.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 61.83 -143.12 48.54 Favored Glycine 0 CA--C 1.534 1.224 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -173.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -75.51 117.27 17.11 Favored 'General case' 0 N--CA 1.455 -0.222 0 O-C-N 121.577 -0.955 . . . . 0.0 109.968 -169.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -120.02 9.47 11.21 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -176.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 95.49 44.32 3.22 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 110.698 -0.961 . . . . 0.0 110.698 -172.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -135.51 165.02 26.49 Favored 'General case' 0 CA--C 1.531 0.238 0 N-CA-C 103.742 -2.688 . . . . 0.0 103.742 160.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -76.55 -56.68 4.4 Favored 'General case' 0 CA--C 1.518 -0.261 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 45.6 m80 -69.56 -61.17 1.89 Allowed 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.643 -1.162 . . . . 0.0 108.908 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . 64.04 -67.0 0.11 Allowed 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 127.166 2.186 . . . . 0.0 113.933 178.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.597 ' CZ ' ' HA ' ' A' ' 198' ' ' ASP . 0.5 OUTLIER -166.93 171.78 10.9 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 124.001 0.92 . . . . 0.0 108.782 -152.285 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 8.4 p30 -174.64 20.97 0.01 OUTLIER 'General case' 0 CA--C 1.531 0.238 0 O-C-N 123.76 0.663 . . . . 0.0 112.564 -169.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 54.55 -142.61 33.11 Favored Glycine 0 CA--C 1.529 0.907 0 N-CA-C 111.141 -0.784 . . . . 0.0 111.141 -172.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -70.75 106.26 3.5 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.102 0.561 . . . . 0.0 111.86 -168.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 110.94 -150.41 17.8 Favored Glycine 0 C--N 1.337 0.596 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 176.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 54.61 -118.06 9.0 Favored Glycine 0 C--N 1.338 0.656 0 N-CA-C 110.285 -1.126 . . . . 0.0 110.285 -177.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 18.7 mm -76.97 127.1 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 172.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.737 ' HB2' ' H1 ' ' A' ' 269' ' ' NGH 0.43 6.9 mp -83.9 -39.22 20.1 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 124.293 1.037 . . . . 0.0 110.014 169.419 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.411 ' O ' ' N1 ' ' A' ' 269' ' ' NGH . . . -177.3 161.13 1.77 Allowed 'General case' 0 C--O 1.242 0.674 0 CA-C-N 119.181 0.901 . . . . 0.0 112.771 172.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . . . . . . . . . 32.1 p-80 -140.03 121.84 15.45 Favored 'General case' 0 C--O 1.225 -0.187 0 C-N-CA 124.226 1.01 . . . . 0.0 112.175 -170.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -151.38 159.34 44.31 Favored 'General case' 0 N--CA 1.447 -0.599 0 C-N-CA 126.329 1.851 . . . . 0.0 106.593 -172.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 65.5 m-85 -149.94 155.82 40.64 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 178.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -103.69 -85.4 1.86 Allowed Glycine 0 CA--C 1.53 1.011 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 173.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -70.23 84.53 0.73 Allowed 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 124.063 3.175 . . . . 0.0 111.007 -174.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -160.46 167.04 35.56 Favored Glycine 0 CA--C 1.523 0.549 0 N-CA-C 108.627 -1.789 . . . . 0.0 108.627 170.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 5.7 m -78.03 166.55 22.68 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 122.817 0.447 . . . . 0.0 110.228 179.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 53.01 -100.25 0.06 OUTLIER Glycine 0 C--N 1.338 0.672 0 C-N-CA 124.185 0.898 . . . . 0.0 112.672 170.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 7.1 tp -59.49 -40.43 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.741 0 CA-C-O 118.275 -0.869 . . . . 0.0 109.426 -178.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -38.49 134.63 1.3 Allowed Glycine 0 CA--C 1.534 1.264 0 C-N-CA 124.026 0.822 . . . . 0.0 112.783 176.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 99.21 -43.86 1.77 Allowed Glycine 0 CA--C 1.533 1.209 0 C-N-CA 125.524 1.535 . . . . 0.0 111.142 -163.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -85.61 152.82 22.83 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 117.989 0.894 . . . . 0.0 109.546 -160.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -128.91 121.29 27.81 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 123.002 0.521 . . . . 0.0 111.873 -171.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . . . . . . . . . 2.1 m170 -109.2 112.8 25.17 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 118.16 -0.924 . . . . 0.0 110.175 -167.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -97.97 151.37 20.37 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 118.897 0.771 . . . . 0.0 112.317 -177.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.597 ' HA ' ' CZ ' ' A' ' 174' ' ' PHE . 3.0 t70 -75.22 66.49 1.72 Allowed 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.332 -176.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -46.81 -41.35 15.35 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 120.183 -1.573 . . . . 0.0 110.996 178.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -49.67 -31.28 10.68 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 118.573 0.624 . . . . 0.0 112.623 177.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -71.8 165.46 24.04 Favored 'General case' 0 C--O 1.243 0.736 0 CA-C-O 123.411 1.577 . . . . 0.0 112.269 172.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -107.23 90.1 3.2 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.073 -1.421 . . . . 0.0 107.422 177.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -77.15 152.33 34.93 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.058 -0.974 . . . . 0.0 108.57 -178.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 61.5 p -132.39 152.49 51.43 Favored 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 121.419 0.628 . . . . 0.0 110.302 178.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.88 -50.56 16.51 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 170.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -69.51 171.22 9.16 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 173.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -49.28 -53.93 19.42 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 125.834 1.654 . . . . 0.0 110.326 -174.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 39.38 -106.89 0.06 OUTLIER Glycine 0 CA--C 1.528 0.864 0 C-N-CA 125.893 1.711 . . . . 0.0 114.273 170.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -107.6 -81.38 1.36 Allowed Glycine 0 CA--C 1.524 0.623 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 -177.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 4.4 m -119.36 137.44 53.72 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 170.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -86.2 124.73 32.92 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 119.843 -0.743 . . . . 0.0 111.177 176.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -53.61 -57.26 11.41 Favored 'General case' 0 C--N 1.341 0.209 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -49.26 -46.15 45.78 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 123.681 0.793 . . . . 0.0 110.405 -178.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 6.0 tt -63.08 -59.07 5.29 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.387 0.675 . . . . 0.0 110.037 -171.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . 0.278 5.0 m -57.27 -42.2 81.19 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 120.4 -0.52 . . . . 0.0 109.992 176.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -51.59 -53.09 41.98 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 117.4 -1.286 . . . . 0.0 110.935 178.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . . . . . . . . . 79.1 t -47.04 -53.51 3.25 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 120.896 1.68 . . . . 0.0 111.176 177.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.694 ' ND1' ' H4 ' ' A' ' 269' ' ' NGH . 3.2 t-160 -52.13 -60.09 3.61 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.674 1.59 . . . . 0.0 110.986 175.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -61.71 -37.33 83.77 Favored 'General case' 0 CA--C 1.535 0.386 0 O-C-N 120.624 -1.297 . . . . 0.0 112.767 -177.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . . . . . . . . . 1.3 mp -71.27 -36.35 61.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 O-C-N 120.952 -1.093 . . . . 0.0 108.335 -177.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . 0.411 ' HA3' ' SD ' ' A' ' 236' ' ' MET . . . -54.51 -47.55 69.21 Favored Glycine 0 CA--C 1.537 1.441 0 O-C-N 121.426 -0.796 . . . . 0.0 111.722 165.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 7.5 m-70 -53.15 -47.77 68.47 Favored 'General case' 0 C--N 1.345 0.379 0 CA-C-N 118.421 1.111 . . . . 0.0 109.83 173.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . . . . . . . . . 32.9 t -52.95 -45.65 67.8 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 123.952 0.783 . . . . 0.0 111.136 179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.496 HD21 ' CZ ' ' A' ' 149' ' ' PHE . 22.0 mt -55.64 -53.64 54.04 Favored 'General case' 0 C--N 1.341 0.199 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 174.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 143.81 52.86 0.03 OUTLIER Glycine 0 C--N 1.334 0.469 0 O-C-N 123.633 0.583 . . . . 0.0 112.665 169.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.716 HD11 HG22 ' A' ' 258' ' ' ILE . 6.5 mt -106.55 117.83 35.08 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -169.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -73.9 95.64 0.83 Allowed Glycine 0 CA--C 1.528 0.873 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 167.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 51.5 m80 7.84 113.75 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 128.47 2.708 . . . . 0.0 116.824 163.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 15.4 m -75.46 179.54 5.19 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.252 0.548 . . . . 0.0 110.592 175.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 10.5 m -136.49 30.2 2.92 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.815 1.246 . . . . 0.0 110.342 -170.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -129.77 139.81 36.76 Favored Pre-proline 0 N--CA 1.45 -0.442 0 C-N-CA 125.55 1.54 . . . . 0.0 107.255 -175.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -84.09 -16.54 6.15 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.336 2.024 . . . . 0.0 114.416 -173.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 14.8 mtmt -82.02 -33.65 29.93 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.657 0.783 . . . . 0.0 108.914 173.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -60.04 146.99 40.8 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.325 0.583 . . . . 0.0 109.814 171.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 90.9 t -95.06 -23.76 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 114.991 -1.004 . . . . 0.0 109.431 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . 0.411 ' SD ' ' HA3' ' A' ' 221' ' ' GLY . 1.4 mmm -63.83 -16.22 60.77 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.598 ' O ' ' CE1' ' A' ' 218' ' ' HIS . 0.1 OUTLIER -53.32 160.8 1.61 Allowed Pre-proline 0 CA--C 1.543 0.7 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -176.897 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.403 ' O ' ' H5 ' ' A' ' 269' ' ' NGH . 74.2 Cg_endo -72.58 -19.08 25.03 Favored 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 121.157 1.238 . . . . 0.0 111.152 175.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . 0.272 0.0 OUTLIER -76.81 -178.23 4.74 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 126.12 1.768 . . . . 0.0 110.448 -176.086 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 58.1 t80 -131.4 144.03 50.91 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 172.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -152.29 129.99 11.58 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 174.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -60.87 122.65 15.38 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 4.0 m -119.92 143.08 32.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 C-N-CA 123.896 0.879 . . . . 0.0 110.345 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -73.09 113.56 10.27 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.716 0.807 . . . . 0.0 110.747 177.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -65.91 -8.88 7.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.912 168.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -68.43 -65.93 0.64 Allowed 'General case' 0 C--N 1.34 0.154 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 167.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 22.4 m -58.89 -43.86 91.04 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 124.57 1.148 . . . . 0.0 111.264 -176.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.736 ' CE1' HG22 ' A' ' 140' ' ' VAL . 7.4 t80 40.64 85.02 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.042 1.337 . . . . 0.0 114.35 165.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 1.5 ppt_? -160.27 176.53 11.61 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 167.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.474 HD22 ' N ' ' A' ' 250' ' ' LEU . 1.5 mm? -102.96 159.95 15.05 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.335 1.054 . . . . 0.0 109.227 178.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 20.9 m -80.03 153.58 28.72 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 116.733 -0.212 . . . . 0.0 111.184 178.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -53.85 -46.98 71.41 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 122.887 0.475 . . . . 0.0 110.37 174.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -49.21 -56.62 8.71 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 122.079 0.942 . . . . 0.0 109.999 173.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -57.9 -46.11 85.42 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 114.308 -1.314 . . . . 0.0 109.981 -174.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 58.8 mt -51.99 -36.66 20.22 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.475 0 C-N-CA 125.836 1.654 . . . . 0.0 112.103 175.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 89.2 mtt180 -66.71 -50.15 63.74 Favored 'General case' 0 C--O 1.231 0.13 0 O-C-N 120.465 -1.397 . . . . 0.0 110.158 174.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -47.12 -56.64 7.66 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.29 -1.124 . . . . 0.0 110.29 176.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.88 HG21 ' CZ3' ' A' ' 141' ' ' TRP . 2.1 pp -64.23 -41.27 91.87 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.128 0 O-C-N 122.404 -0.468 . . . . 0.0 111.111 -175.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -60.63 -28.59 68.66 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 120.773 -1.204 . . . . 0.0 111.58 174.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.15 -6.48 1.44 Allowed 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 169.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 33.9 mt -62.4 -2.97 1.18 Allowed 'General case' 0 CA--C 1.545 0.784 0 O-C-N 118.247 -2.783 . . . . 0.0 115.615 175.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . 0.435 ' CD2' ' HA3' ' A' ' 263' ' ' GLY 0.3 0.9 OUTLIER -72.93 -54.07 9.64 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 121.805 2.093 . . . . 0.0 111.259 -179.684 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . 0.435 ' HA3' ' CD2' ' A' ' 262' ' ' TYR . . . . . . . . 0 C--O 1.252 1.255 0 C-N-CA 130.218 3.77 . . . . 0.0 117.618 -38.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' NGH . . . . . 0.737 ' H1 ' ' HB2' ' A' ' 181' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_